中国科学院机构知识库网格系统: 检索

浏览/检索结果: 共8条，第1-8条

帮助

条数/页：排序方式：
	Multidisciplinary team quality improves the survival outcomes of locally 期刊论文 OAI收割 RADIOTHERAPY AND ONCOLOGY, 2024, 卷号: 200 作者: Ma, Huiying; Li, Haoyue; Xu, Tongzhen; Gao, Yuanhong; Liu, Shixin \| 收藏 \| 浏览/下载：8/0 \| 提交时间：2024/11/20 Rectal cancer Multidisciplinary team quality Survival
	Systemic Therapy for Hepatocellular Carcinoma: Chinese Consensus-Based Interdisciplinary Expert Statements 期刊论文 OAI收割 LIVER CANCER, 2022, 卷号: 11 作者: Sun, Yongkun; Zhang, Wen; Bi, Xinyu; Yang, Zhengqiang; Tang, Yu \| 收藏 \| 浏览/下载：60/0 \| 提交时间：2022/12/23 Chinese interdisciplinary experts Hepatocellular carcinoma Molecular targeted therapy Consensus
	Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR) 期刊论文 OAI收割 JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40 作者: Jin, Jing; Tang, Yuan; Hu, Chen; Jiang, Li-Ming; Jiang, Jun \| 收藏 \| 浏览/下载：36/0 \| 提交时间：2022/12/23
	Anlotinib in Locally Advanced or Metastatic Medullary Thyroid Carcinoma: A Randomized, Double-Blind Phase IIB Trial 期刊论文 OAI收割 CLINICAL CANCER RESEARCH, 2021, 卷号: 27 作者: Li, Dapeng; Chi, Yihebali; Chen, Xiaohong; Ge, Minghua; Zhang, Yuan \| 收藏 \| 浏览/下载：54/0 \| 提交时间：2021/08/31
	Anlotinib in radioiodine-refractory differentiated thyroid carcinoma: A subanalysis based on ALTER01032 study for patients with poor baseline characteristics. 期刊论文 OAI收割 JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39 作者: Chi, Yihebali; Gao, Ming; Zhang, Yuan; Shi, Feng; Cheng, Ying \| 收藏 \| 浏览/下载：32/0 \| 提交时间：2022/01/10
	Health-related quality-of-life results from SANET-ep: A phase III study of surufatinib versus placebo for advanced extrapancreatic neuroendocrine tumors. 期刊论文 OAI收割 JOURNAL OF CLINICAL ONCOLOGY, 2020, 卷号: 38 作者: Bai, Chunmei; Xu, Jianming; Shen, Lin; Li, Jie; Zhou, Zhiwei \| 收藏 \| 浏览/下载：64/0 \| 提交时间：2020/11/30
	Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors 期刊论文 OAI收割 JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 卷号: 9 作者: Sun, Yongkun; Niu, Wei; Du, Feng; Du, Chunxia; Li, Shuting \| 收藏 \| 浏览/下载：47/0 \| 提交时间：2019/01/08 Anlotinib Anti-angiogenesis Phase I study Advanced refractory solid tumors Pharmacokinetics Safety
	Safety, pharmacokinetic, and antitumor activity of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors. 会议论文 OAI收割作者: Sun, Yongkun; Niu, Wei; Chi, Yihebali; Li, Chuan; Du, Chun-Xia \| 收藏 \| 浏览/下载：24/0 \| 提交时间：2019/01/08